|
½ÉÀå °Ç° : OTC Á¦Ç° ºÐ¼®
Heart Health: Exploring the OTC Options
|
¸®¼Ä¡»ç |
Nicholas Hall & Company
|
¹ßÇàÀÏ |
2017³â 06¿ù |
»óǰ ÄÚµå |
482401 |
ÆäÀÌÁö Á¤º¸ |
¿µ¹® 183 Pages |
°¡°Ý |
|
½ÉÀå °Ç° : OTC Á¦Ç° ºÐ¼®
Heart Health: Exploring the OTC Options
|
¹ßÇàÀÏ : 2017³â 06¿ù | ÆäÀÌÁö Á¤º¸ : ¿µ¹® 183 Pages |
|
|
½ÉÀåÀÇ °Ç° À¯Áö¸¦ À§ÇÑ °¢Á¾ OTC Á¦Ç° ½ÃÀåÀ» Á¶»çÇßÀ¸¸ç, ½ÉÇ÷°üÁúȯÀÇ °³¿ä, ½ÉÀåÀÇ °Ç° À¯Áö¸¦ À§ÇÑ OTC Á¦Ç°ÀÇ Á¾·ù¿Í °³¿ä, ÁÖ¿ä Á¦Ç° ºÎ¹® ¹× ÁÖ¿ä Áö¿ª¡¤±¹°¡º° µ¿Çâ, ºê·£µå ÆÛÆ÷¸Õ½º, ½ÅÁ¦Ç° °³¹ß¡¤½ÃÀå ÅõÀÔ µîÀÇ µ¿Çâ, ÁÖ¿ä ¼ººÐ¿¡ ´ëÇÑ °úÇÐÀû ¿¬±¸ÀÇ µ¿Çâ, ÁÖ¿ä ±â¾÷¡¤Á¦Ç°ÀÇ »ç·Ê ¿¬±¸, ÇâÈÄ Àü¸Á µîÀ» Á¤¸®ÇÏ¿© ÀüÇØµå¸³´Ï´Ù.
1. °³¿ä
- °³¿ä
- ½ÉÇ÷°üÁúȯ : ¼¼°è ÃÖ´ëÀÇ »ç¸Á ¿øÀÎ
- ½ÉÇ÷°üÁúȯÀ̶õ?
- ½ÉÇ÷°üÁúȯÀÇ À§ÇèÀÎÀÚ
- ÁÖ¿ä ½ÃÀåÀÇ ½ÉÀå °Ç° : ¿ì·ÁÀÇ ¼¼°èÀû È®»ê
- ½ÉÀå °Ç° À¯Áö¸¦ À§ÇÑ OTC Á¦Ç° : ±¤¹üÀ§ÇÑ ¿É¼Ç
- ½ÉÀå °Ç° À¯Áö¸¦ À§ÇÑ OTC Á¦Ç° : °³¿ä
- °íÇ÷¾Ð ȯÀÚ¿ë OTC
- ÄÝ·¹½ºÅ×·Ñ °¨¼Ò¸¦ À§ÇÑ RX ½ºÅ¸Æ¾ ¼·ÃëÀÚ¼öÀÇ Áõ°¡
- ½ºÅ¸Æ¾ : OTCÈ ½ÇÆÐ
- OTC ÄÝ·¹½ºÅ×·Ñ °Ë»ç¾à
- ±â¼ú°ú ½ÉÀå °Ç°
- ½ÉÀå °Ç° À¯Áö¸¦ À§ÇÑ OTC Á¦Ç° : Àå·¡¼º
- ½ÉÀå °Ç° À¯Áö¸¦ À§ÇÑ OTC Á¦Ç° : Á¼¾ÆÁö´Â ³²³à °ÝÂ÷
- °úÇÐÀû ¿¬±¸ : ½ÃÀå ¼ºÀåÀÇ »õ·Î¿î °æ·Î °³Ã´ °¡´É¼º
2. Àü½Å¼º ½ÉÇ÷°ü°Ç° À¯Áö Á¦Ç°
- °³¿ä
- ¼À¯·´
- ÁßÀ¯·´¡¤µ¿À¯·´
- ºÏ¹Ì
- ºê·£µå »ç·Ê ¿¬±¸ : Berkeley Life Heart Health
- ºê·£µå »ç·Ê ¿¬±¸ : HearShape / Synastat
- ¾Æ½Ã¾ÆÅÂÆò¾ç
- ¶óƾ¾Æ¸Þ¸®Ä«
- ÇÇÅ佺Å×·Ñ : OTC ÄÝ·¹½ºÅ×·Ñ °ü¸®ÀÇ ÇÁ·¹Àü½º È®´ë
- ÇÇÅ佺Å׷Ѱú ½ºÅ¸³î¿¡ ´ëÇÑ ÃÊÁ¡
- Àü¸Á
3. ¾îÀ¯ & ¿À¸Þ°¡ 3
- °³¿ä
- ºÏ¹Ì
- ºê·£µå »ç·Ê ¿¬±¸ : MegaRed
- ¾Æ½Ã¾ÆÅÂÆò¾ç
- ¼À¯·´
- ¶óƾ¾Æ¸Þ¸®Ä«
- ÁßÀ¯·´¡¤µ¿À¯·´
- Àü¸Á
4. CoQ10 ¼Çø®¸ÕÆ®
- °³¿ä
- ºÏ¹Ì
- ºê·£µå »ç·Ê ¿¬±¸ : Qunol
- ¾Æ½Ã¾ÆÅÂÆò¾ç
- ¼À¯·´
- ÁßÀ¯·´¡¤µ¿À¯·´
- Àü¸Á
5. ¸¶´Ã ¼Çø®¸ÕÆ®
- °³¿ä
- ¾Ë¸®½Å : ¸¶´ÃÀÇ ÈÇÐ
- ¾Æ½Ã¾ÆÅÂÆò¾ç
- ºÏ¹Ì
- ¼À¯·´
- ºê·£µå »ç·Ê ¿¬±¸ : Kwai
- ±âŸ Áö¿ª
- Àü¸Á
6. ½ÉÀå °Ç° À¯Áö¸¦ À§ÇÑ ±âŸ ¼Çø®¸ÕÆ®
- ÁÖ¿ä ÀλçÀÌÆ®
- ¸ÖƼºñŸ¹Î
- ºê·£µå »ç·Ê ¿¬±¸ : Centrum
- ´ÜÀÏ ºñŸ¹Î
- ¸¶±×³×½· ¼Çø®¸ÕÆ®(+Ä®·ý)
- ÇÁ·Î¹ÙÀÌ¿Àƽ½º
- ºê·£µå »ç·Ê ¿¬±¸ : PureHeart
- ·¹½Ãƾ ¼Çø®¸ÕÆ®
- ¾Æ¸¶¾¾À¯ ¼Çø®¸ÕÆ®
- ±âŸ Çãºê¡¤ÀÚ¿¬ À¯·¡ ¼Çø®¸ÕÆ®
- ºê·£µå »ç·Ê ¿¬±¸ : i-Cool for Menopause plus Omega-3
7. °úÇÐÀû ¿¬±¸
- °³¿ä
- ºñŸ¹Î D
- ºñŸ¹Î K2
- ºñŸ¹Î B
- Ä®·ý
- ¸¶±×³×½·
- ¸¶´Ã
- ¿À¸Þ°¡ 3
- ¿À¸Þ°¡ 7/ ½Ã¹÷Åæ(Sea buckthorn)
- ÇÁ·Î¹ÙÀÌ¿Àƽ½º
- ¿ÀÆ® º£Å¸ ±Û·çÄ
- °ï¾à ±Û·çÄÚ¸¸³
- »ýȰ½À°üº´¡¤½ÉÀ庴
- °úÇÐÀû ¿¬±¸ : ±âÁ¸ ¼Çø®¸ÕÆ®ÀÇ ÀçȰ¼ºÈ¿Í »õ·Î¿î Æ´»õ ½ÃÀå¿¡ ´ëÇÑ ÁÖ¸ñ
8. ½ÉÀå °Ç° À¯Áö : ³²³àº° Â÷ÀÌ
- ½ÉÀå Áúȯ : ¿©¼º¿¡ ´ëÇÑ Ä§¹¬ÀÇ »ìÀÎÀÚ(silent killer)
- ½ÉÀå ¹ßÀÛ : ³²¼º vs ¿©¼º
- ¿©¼ºÀÇ À§ÇèÀÎÀÚ
- ÀÎÁöµµ Çâ»ó ±¸»ó
- Áõ»ó : ³²³à¿¡ µû¶ó ´Ù¸¥ ¡ÈÄ
- ¹ÎÁ·¼º : Á¦¾î ºÒ°¡ À§ÇèÀÎÀÚ?
- ½ÉÀå °Ç° À¯Áö¸¦ À§ÇÑ OTC ºê·£µå Á¦Ç°
- »ç·Ê ¿¬±¸ : Centrum
- »ç·Ê ¿¬±¸ : Bayer Aspirin
KSA 17.06.21
More people die annually from cardiovascular diseases than from any other cause; it is the leading cause of death for both men and women.
Our newest report on Heart Health takes an in-depth look into this category, giving insight into the latest trends with detailed market analysis.
Key benefits of this report include:
- An in-depth exploration of OTC heart health options, including systemic cardiovasculars, fish oils & omega-3 supplements, CoQ10, garlic and other supplements
- Gauging the size of the market in individual countries, plus brand performances, new developments, launches and A+P campaigns
- Coverage of all the major markets (and some smaller ones), including Canada, China, France, Germany, Italy, Japan, Poland, Russia, S Korea, UK, USA, and more
- Full year 2016 OTC sales direct from the freshly-published DB6, our dedicated OTC sales database
What this report covers:
- Systemic cardiovasculars
- Fish oils & omega-3
- CoQ10 supplements
- Garlic supplements
- Plus health-focused brands from: Multivitamins
- Single vitamins
- Mineral supplements
- Probiotics
- Case studies of key heart health brands highlight success factors, sales and A+P activity
- Investigating the gender divide: how most heart health products tend to target men, largely missing the important underdeveloped segment for women's heart health
- Forecast sales for all heart health categories, and a look forward to potential opportunities, including switches, new ingredients and clinical studies
Table of Contents
Executive summary
- Overview
- Cardiovascular diseases are the world's biggest killer
- What are cardiovascular diseases?
- Risk factors for cardiovascular diseases
- Heart health in key markets - growing issue globally
- Wide array of OTC options for heart health
- OTC heart health market - Overview
- OTCs for consumers with high blood pressure
- Number of people taking RX statins for cholesterol reduction is on the rise
- Statins have failed to take off OTC
- OTC cholesterol tests
- Technology and heart health
- What does the future hold for OTC heart health?
- Gender divide among heart health OTCs narrowing
- Scientific studies could provide new routes to market growth
Systemic cardiovasculars
- Category overview
- Western Europe
- Central & Eastern Europe
- North America
- Brand case study: Berkeley Life Heart Health
- Brand cast study: HearShape / Synastat
- Asia-Pacific
- Latin America
- Phytosterols a growing presence in OTC cholesterol management
- Focus on phytosterols and stanols
- Outlook
Fish oils & omega-3
- Category overview
- North America
- Brand case study: MegaRed
- Asia-Pacific
- Western Europe
- Latin America
- Central & Eastern Europe
- Outlook
CoQ10 supplements
- Category overview
- North America
- Brand case study: Qunol
- Asia-Pacific
- Western Europe
- Central & Eastern Europe
- Outlook
Garlic supplements
- Category overview
- Allicin: the chemistry behind garlic
- Asia-Pacific
- North America
- Western Europe
- Brand case study: Kwai
- Other region
- Outlook
Other supplements for heart health
- Key insights
- Multivitamins
- Brand case study: Centrum
- Single vitamins
- Magnesium supplements (plus potassium)
- Probiotics
- Brand case study: PureHeart
- Lecithin supplements
- Flaxseed oil supplements
- Other herbal & natural supplements
- Brand case study: i-Cool for Menopause plus Omega-3
Scientific studies
- Overview
- Vitamin D
- Vitamin K2
- Vitamin B
- Potassium
- Magnesium
- Garlic
- Omega-3
- Omega-7 / Sea buckthorn
- Probiotics
- Oat beta-glucan
- Konjac glucomannan
- Lifestyle & heart disease
- Scientific studies key to revitalising existing supplements and highlighting new niches
The gender divide in heart health
- Heart disease: The silent killer amid women
- Heart attacks: Men vs women
- Risk factors for women
- Awareness initiatives
- Symptoms: Different genders, different signs
- Ethnicity: The uncontrollable risk factor?
- Are OTC heart health brands missing the vital female demographic?
- Case study: Centrum
- Case study: Bayer Aspirin
|

|
OTC/DTC °¨¿°Áõ Áø´Ü ½ÃÀå(2020-2024³â)
¼¼°èÀÇ ½ÃÆÇ¾à(OTC)¿ë Ç÷¡À̹ö ½ÃÀå
OTC ÀǾàǰ ¹× ½ÄÀ̺¸ÃæÁ¦ : ¼ÒºñÀç À¯Åë¾÷üÀÇ ±âȸ
¹Ì±¹ÀÇ º¸ÃæÁ¦/OTC/Rx(󹿾à) ¼ÒºñÀÚ µ¿Çâ°ú ÀλçÀÌÆ® º¸°í¼ : Á¦8ÆÇ
Àεµ³×½Ã¾ÆÀÇ º¸ÃæÁ¦/OTC/Rx(2019³â)
Áß±¹ÀÇ º¸ÃæÁ¦/OTC/Rx(2019³â)
¼¼°èÀÇ Å»¸ðÁõ Ä¡·á ½ÃÀå : ±Ô¸ð, Á¡À¯À², µ¿Ç⠺м®, ¿¹Ãø(2019-2026³â)
¼¼°èÀÇ OTC ÀǾàǰ ½ÃÀå ¿¹Ãø(2018-2028³â) : ±âħ¡¤°¨±â¡¤¾Ë·¹¸£±â¾à, ÁøÅëÁ¦, À§Àå¾à, ÇǺξà, ¾ÆÀÌÄÉ¾î ¿ëǰ, ±Ý¿¬º¸Á¶Á¦ µî
¼¼°èÀÇ ·ù¸¶Æ¼½º °üÀý¿° Ä¡·áÁ¦/Ä¡·á¹ý ½ÃÀå ±Ô¸ð Á¶»ç : ºÐÀÚ Á¾·ùº°, ÆÇ¸Åä³Îº°(ó¹æ, ¸ÅÀåÆÇ¸Å(OTC)), Áö¿ªº° ¿¹Ãø
¼¼°èÀÇ ÇコÄÉ¾î ¹°·ù ½ÃÀå ¿¹Ãø(-2024³â) : ÀǾàǰº°(ºê·£µåÀǾàǰ, Á¦³×¸¯ ÀǾàǰ, OTC ÀǾàǰ, ºñŸ¹Î), ÀÇ·á±â±âº°, ¹ÙÀÌ¿À ÀǾàǰº°(¹é½Å, ´ÜŬ·ÐÇ×ü)
|